Rankings
▼
Calendar
KLRS Q1 2019 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena
KLRS
Kalaris Therapeutics Inc
$180M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$165,000
Gross Profit
$0
0.0% margin
Operating Income
-$3M
-1680.6% margin
Net Income
-$3M
-1529.7% margin
EPS (Diluted)
$-0.89
← FY 2019
All Quarters
Q2 2019 →